--- title: Eyerising International - Advancing Myopia Management description: Eyerising International develops RLRL therapy devices for childhood myopia management. Clinically supported, non-invasive treatment for children aged 3-16. Available through eye-care professionals in 30+ countries. image: https://eyerisinginternational.com/hubfs/eri-web/images/og-default.png --- I am not an eye-care professional I am an eye-care professional Viewing the International site. [![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png)](https://eyerisinginternational.com/?hsLang=en) [Home](https://eyerisinginternational.com/?hsLang=en) [About Us](https://eyerisinginternational.com/about?hsLang=en) [About Eyerising](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory](https://eyerisinginternational.com/regulatory?hsLang=en) [News](https://eyerisinginternational.com/news?hsLang=en) [Latest News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) [Events](https://eyerisinginternational.com/events?hsLang=en) [Contact](https://eyerisinginternational.com/contact?hsLang=en) [Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) [Get in Touch](https://eyerisinginternational.com/contact?hsLang=en) [Home](https://eyerisinginternational.com/?hsLang=en) [About Us](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en) [News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) [Events](https://eyerisinginternational.com/events?hsLang=en) [Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) [Get in Touch](https://eyerisinginternational.com/contact?hsLang=en) Australian MedTech # Repeated low-level red-light therapy for myopia Clinical studies conducted worldwide have reported reductions in axial elongation and slowed myopia progression in children aged 3–16 years, with some trials reporting effects of up to 87.7%.1 Axial shortening has also been observed in 53.3% of high myopia children.2 Our RLRL technology provides clinicians with an evidence-based, non-invasive option for managing myopia within clinical practice. RLRL therapy is a clinically supported, non-invasive treatment for children aged 3–16 to help slow the progression of myopia—administered at home under the supervision of an eye-care professional. Your optometrist will explain how the device works, whether it is suitable for your child, and how it fits within the range of available myopia management options. [Request a Demo Device](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic Near You](https://eyerisinginternational.com/clinics?hsLang=en) ![Eyerising myopia management device](https://eyerisinginternational.com/hs-fs/hubfs/eri-web/images/device-portrait.png?width=550&height=799&name=device-portrait.png) 3 min Per session 2× daily Five days per week 40+ Countries approved ![Child receiving myopia management care](https://eyerisinginternational.com/hs-fs/hubfs/eri-web/images/about-myopia.jpg?width=799&height=533&name=about-myopia.jpg) ## Pioneering Myopia Management Eyerising International is an Australian medical technology company dedicated to advancing repeated low-level red-light (RLRL) therapy for childhood myopia management across the globe. We partner with clinicians, researchers, and distributors to deliver safe, effective, and monitored myopia control solutions. Our mission is to make evidence-based myopia management accessible to children and families worldwide—through rigorous science, trusted clinical relationships, and purpose-built technology. The Eyerising Myopia Management Device is available exclusively through optometrists and ophthalmologists. Outcomes may vary for each patient. Eyerising International is an Australian medical technology company dedicated to advancing repeated low-level red-light (RLRL) therapy for childhood myopia management across the globe. We partner with clinicians, researchers, and distributors to deliver safe, effective, and monitored myopia control solutions. Our mission is to make evidence-based myopia management accessible to children and families worldwide—through rigorous science, trusted clinical relationships, and purpose-built technology. ## What We Offer A complete ecosystem designed to support clinicians and patients at every step of the myopia management journey. ### Online Monitoring System A secure, cloud-based platform giving clinicians real-time visibility into patient treatment compliance, session data, safety, and progress—from anywhere in the world. ### Myopia Management Device A compact, non-invasive home-use device that delivers patented RLRL therapy in just three-minute sessions—designed for daily use by children aged 3–16 under clinical supervision. ### Customer Support Dedicated technical support, onboarding resources, and patient guidance tools to ensure clinicians and families get the most from every treatment session. > "By collaborating with clinicians, researchers, and partners worldwide, we aim to advance the science and practice of myopia management for future generations." > "Our mission is to support eye-care professionals through research, collaboration, and innovation in myopia management." Jason Sun Chief Executive Officer, Eyerising International ## Ready to Learn More? Connect with our team to explore the Eyerising device and discover how our complete solution fits your practice. [Request a Demo Device](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic Near You](https://eyerisinginternational.com/clinics?hsLang=en) [Learn About Our Device](https://eyerisinginternational.com/device?hsLang=en) 1 Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, Xiong R, Yuan Y, Zeng J, Morgan IG, He M. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129(5):509-19. 2 Xu Y, Cui L, Kong M, Li Q, Feng X, Feng K, Zhu H, Cui H, Shi C, Zhang J, Zou H. Repeated Low-Level Red-Light Therapy for Myopia Control in High Myopia Children and Adolescents: A Randomized Clinical Trial. Ophthalmology. 2024 Jun 5:S0161-6420(24)00318-X. doi: 10.1016/j.ophtha.2024.05.023. ![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png) Advancing myopia management through repeated low-level red-light therapy. #### Company - [About Us](https://eyerisinginternational.com/about?hsLang=en) - [Our Team](https://eyerisinginternational.com/team?hsLang=en) - [Our Story](https://eyerisinginternational.com/story?hsLang=en) - [News](https://eyerisinginternational.com/news?hsLang=en) - [Events](https://eyerisinginternational.com/events?hsLang=en) #### Resources - [Our Device](https://eyerisinginternational.com/device?hsLang=en) - [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) - [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en) - [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) - [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) #### Contact Suite 2.05, 9/11 Claremont St South Yarra VIC 3141, Australia [info@eyerisinginternational.com](mailto:info@eyerisinginternational.com) [LinkedIn](https://au.linkedin.com/company/eyerising-international) THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE Ask your optometrist or ophthalmologist for advice to see if this product is right for your child. Outcomes may vary for each patient. The Eyerising Myopia Management Device is exclusively available through eye care professionals (e.g. optometrists, ophthalmologists) for home use. © 2026 Eyerising International. All rights reserved. [LinkedIn](https://au.linkedin.com/company/eyerising-international) [Privacy Policy](https://eyerisinginternational.com/legal?hsLang=en) [Terms & Conditions](https://eyerisinginternational.com/legal?hsLang=en) ## Welcome to Eyerising International To show you the most relevant information, please confirm which best describes you. I am not an Eye-Care Professional I am an Eye-Care Professional ## Disclaimer This website is intended for use by eye care professionals only. By agreeing and proceeding, you are declaring you are a registered eye care professional. If you are not a registered eye care professional, do not proceed. I Agree I Disagree ```json { "@context" : "https://schema.org", "@type" : "MedicalOrganization", "address" : { "@type" : "PostalAddress", "addressCountry" : "AU", "addressLocality" : "South Yarra", "addressRegion" : "VIC", "postalCode" : "3141", "streetAddress" : "Suite 2.05, 9/11 Claremont St" }, "contactPoint" : { "@type" : "ContactPoint", "contactType" : "customer service", "email" : "info@eyerisinginternational.com" }, "description" : "Australian MedTech company advancing repeated low-level red-light (RLRL) therapy for childhood myopia management.", "foundingDate" : "2020", "logo" : "https://43619611.fs1.hubspotusercontent-ap1.net/hubfs/43619611/eri-web/logo-white.png", "name" : "Eyerising International", "sameAs" : [ "https://www.linkedin.com/company/eyerising-international" ], "url" : "https://eyerisinginternational.com" } ```